Observational Study on the Impact of Obstructive Sleep Apnea on Executive Function and Empathy Development in Children
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 12 years old?
Source: NCT06850220, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Children's Hospital of Soochow University
- Trial code
- NCT06850220
- Record updated
- 26 January 2026
- Original description
This study aims to investigate the effects of obstructive sleep apnea (OSA) on executive function and empathy development in children aged 3-12 years. The study will compare the outcomes of different treatment approaches (surgical vs. pharmacological) in children with mild OSA and track the progression of cognitive and emotional functions over 12 months. The study will also explore potential EEG biomarkers for assessing neurological damage in OSA children.Read full original descriptionShow less
This study aims to investigate the effects of obstructive sleep apnea (OSA) on executive function and empathy development in children aged 3-12 years. The study will compare the outcomes of different treatment approaches (surgical vs. pharmacological) in children with mild OSA and track the progression of cognitive and emotional functions over 12 months. The study will also explore potential EEG biomarkers for assessing neurological damage in OSA children.
Inclusion: Children aged 3-12 years; Diagnosed with OSA due to adenoid and/or tonsillar hypertrophy; IQ ≥ 85; Parental consent for participation.
Exclusion: Other primary sleep disorders (e.g., narcolepsy, restless leg syndrome); Developmental delay, epilepsy, or other neurological/metabolic disorders; Chronic diseases or history of head trauma.